Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two related deaths, according to the FDA and CDC.

Friday's federal advisory on Ixchiq arrived amid a crackdown on vaccine ... Health News // 20 hours ago RFK Jr. names 8 new CDC vaccine advisory members, including skeptics June 11 (UPI ...

Results from the Phase II VLA1553-221 trial show that a full dose of Ixchiq demonstrated a 96.5% seroresponse rate in ...

Hold off on inoculating people ages 60 and older against chikungunya infection with the Ixchiq vaccine, the FDA and CDC jointly recommended amidst an investigation into adverse events. Two ...

The FDA said it will conduct an updated benefit-risk assessment for the use of Ixchiq in the 60-and-up age bracket and that both the agency and the CDC will continue monitoring safety reports for ...

Due to an ongoing investigation of serious adverse events, it is recommended that the use of Ixchiq ® (chikungunya ... for Disease Control and Prevention (CDC). According to the Agencies, as ...

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) issued advisories late last week regarding the vaccine Ixchiq, developed by Valneva. Chikungunya is ...

"FDA and CDC will continue the evaluation of post-marketing safety reports for Ixchiq," the release reads. READ ON THE FOX NEWS APP "While the safety of Ixchiq for use in individuals 60 years of ...

May 12 (UPI) --U.S. health officials are advising patients using the drug Ixchiq to hold off while authorities ... was initiated Friday by the FDA and CDC while the two federal agencies ...

Older adults are being warned against receiving the chikungunya vaccine before traveling. The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved ...